Donepezil in vascular dementia: a randomized, placebo-controlled study

Objective: To evaluate the efficacy and tolerability of donepezil in patients with vascular dementia (VaD). Methods: Patients (n = 616; mean age, 75.0 years) with probable or possible VaD, according to National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherc...

Full description

Bibliographic Details
Main Authors: Wilkinson, D. (Author), Doody, R. (Author), Helme, R. (Author), Taubman, K. (Author), Mintzer, J (Author), Kertesz, A. (Author), Pratt, R.D., Donepezil 308 Study Group (Author)
Format: Article
Language:English
Published: 2003-08.
Subjects:
Online Access:Get fulltext